Cape Investment Advisory, Inc. Syndax Pharmaceuticals Inc Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 6,427 shares of SNDX stock, worth $98,204. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,427
Previous 2,500
157.08%
Holding current value
$98,204
Previous $48.1 Million
76.55%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
233Shares Held
96.9MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$130 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$121 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$90.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$81.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$74.6 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $864M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...